Oramed Pharmaceuticals In...
2.35
-0.01 (-0.42%)
At close: Jan 15, 2025, 3:59 PM
2.34
-0.21%
After-hours Jan 15, 2025, 04:00 PM EST

Oramed Pharmaceuticals Inc. Forecast

Stock Price Forecast

The 1 analysts with 12-month price forecasts for ORMP stock have an median target of 0, with a low estimate of 0 and a high estimate of 0. The median target predicts a decrease of 0% from the current stock price of 2.35.

Analyst Consensus: Hold
Target Low Average Median High
Price $0 $0 $0 $0
Change 0% 0% 0% 0%

AI Analyst Report

According to 1 stock analyst, the rating for Oramed Pharmaceuticals Inc. is "Hold". This means that the analyst believes this stock is likely to lead to similar returns than market as a whole.

Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Total

Financial Forecast this Year

Revenue This Year
750.00K
from 1.34M
Increased by -44%
Revenue Next Year
1.00M
from 750.00K
Increased by 33.3%
EPS This Year
-0.24
from 0.14
Increased by -71.4%
EPS Next Year
-0.12
from -0.24
Increased by 50.0%